By bringing together a formidable and diverse group of researchers, patient advocacy groups, physicians, and health professionals within the kidney cancer community, the Kidney Cancer Impact Alliance (KCIA) hopes to advance education about research into, and access to, high-quality care for people with kidney cancer.

According to the American Cancer Society, kidney cancer is among the ten most common cancers among American men and women. In 2022, an estimated 50,290 men and 28,710 women will be newly diagnosed with kidney cancer. It is estimated that more than 13,290 of those diagnosed in 2022 will die from this disease.[1]

“This Alliance is about reimagining the possibilities for better patient outcomes and equitable access to care for people diagnosed with this potentially deadly disease,” said Harris M. Nagler, president of the Urology Care Foundation, a KCIA stakeholder organization and the official Foundation of the American Urological Association (AUA).

“By joining forces as the KCIA, we intend to scale our network, improve health outcomes and make a profound impact on the kidney cancer community, including the millions of people living with the disease.”

The Kidney Cancer Impact Alliance is organized as a diverse group of stakeholders who collectively seek to advance education about, research into, and access to high-quality care for people with kidney cancer. The goal of the KCIA is to:

Advertisement #3
  • Raise awareness about prevalence and implications;
  • Advocate to protect and secure funding for research;
  • Increase access to skilled specialists and improved treatments; and
  • Promote collaboration between stakeholder groups.

“The outlook for people impacted by kidney cancer has changed dramatically. In 2021 alone, there were five new drug or regimen approvals. Yet, as exciting as advancements like these are, there is much more work to be done, which is why the Kidney Cancer Association is honored to be an inaugural member of the KCIA’s steering committee,” noted Gretchen E. Vaughan, president, and CEO of the Kidney Cancer Association.

“We are excited to come together with one voice to address the needs of our community, build on the momentum of the past 30 years and make a meaningful impact on the lives of those facing kidney cancer,” Vaughan added.

KCIA members have already collaborated on a number of issues including a letter to the Biden Administration encouraging the prioritization of policy that supports a diversity of research and the needs of those living with kidney cancer, as well as the hosting of informational webinars on the Congressionally Directed Medical Research Programs (CDMRP) and hosting a virtual Advocacy Day to encourage Members of Congress to support medical research funding for kidney cancer.

[1] Key Statistics About Kidney Cancer. American Cancer Society. Online. Last accessed March 24, 2022.

Feature image: Human kidney cross-section. Photo courtesy: © 2019 Fotolia/Adobe. used with permission.

Advertisement #5